Pituitary Tumor Treatments
Find Pituitary Tumor Treatments
Medications for Pituitary Tumor
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Pituitary Tumor.
Found 3 Approved Drugs for Pituitary Tumor
Cabergoline
Generic Name
Cabergoline
Cabergoline
Generic Name
Cabergoline
Form: Tablet
Method of administration: Oral
FDA approval date: March 07, 2007
Classification: Ergot Derivative
Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
Cortrosyn
Generic Name
Cosyntropin
Cortrosyn
Generic Name
Cosyntropin
Form: Injection
Method of administration: Intravenous, Parenteral, Intramuscular
FDA approval date: August 01, 2003
Classification: Adrenocorticotropic Hormone
CORTROSYN is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. CORTROSYN is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.
Synarel
Generic Name
Nafarelin acetate
Synarel
Generic Name
Nafarelin acetate
Form: Spray
Method of administration: Nasal
FDA approval date: February 13, 1990
Classification: Gonadotropin Releasing Hormone Receptor Agonist
FOR CENTRAL PRECOCIOUS PUBERTY (For Endometriosis, See Reverse Side ) SYNAREL is indicated for treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes. The diagnosis of central precocious puberty (CPP) is suspected when premature development of secondary sexual characteristics occurs at or before the age of 8 years in girls and 9 years in boys, and is accompanied by significant advancement of bone age and/or a poor adult height prediction. The diagnosis should be confirmed by pubertal gonadal sex steroid levels and a pubertal LH response to stimulation by native GnRH. Pelvic ultrasound assessment in girls usually reveals enlarged uterus and ovaries, the latter often with multiple cystic formations. Magnetic resonance imaging or CT-scanning of the brain is recommended to detect hypothalamic or pituitary tumors, or anatomical changes associated with increased intracranial pressure. Other causes of sexual precocity, such as congenital adrenal hyperplasia, testotoxicosis, testicular tumors and/or other autonomous feminizing or masculinizing disorders must be excluded by proper clinical hormonal and diagnostic imaging examinations. FOR ENDOMETRIOSIS (For Central Precocious Puberty, See Reverse Side ) SYNAREL is indicated for management of endometriosis, including pain relief and reduction of endometriotic lesions. Experience with SYNAREL for the management of endometriosis has been limited to women 18 years of age and older treated for 6 months.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances